BioSpace News Archive

Orchard Therapeutics, a global gene therapy leader, announced its marketing authorization application for Libmeldy® has been accepted for evaluation by the Swiss Agency for Therapeutic Products for the potential treatment of eligible patients with early-onset metachromatic leukodystrophy.

BioXcel Therapeutics, Inc., announced that Vimal Mehta, Ph.D., Founder and Chief Executive Officer, and Matt Wiley, Chief Commercial Officer, will participate in a virtual fireside chat at the Bank of America 2022 Biotech SMID Cap Conference on Wednesday, December 7, 2022 at 1:45 p.m. Eastern Time.

Kymera Therapeutics, Inc., a clinical-stage biopharmaceutical company advancing targeted protein degradation to deliver novel small molecule protein degrader medicines, shared webcast information for the virtual investor event that the Company will host on December 14, 2022, from 8:00-9:30 AM ET.

Tonix Pharmaceuticals Holding Corp. presented data from the Company’s TNX-801 smallpox and monkeypox vaccine development program in an oral presentation at the World Vaccine and Immunotherapy Congress 2022, being held in San Diego, Calif., November 28 - December 1, 2022.

Applied Genetic Technologies Corporation, announced the successful completion of the previously announced tender offer to purchase all of the issued and outstanding shares of common stock of AGTC by a portfolio company of Syncona Limited .

Krystal Biotech, Inc. a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, announced that the Company will participate in the BofA Securities 2022 Biotech SMID Cap Conference, which is taking place virtually from December 7-8.

UCB, a global biopharmaceutical company, today announced that data from its anti-seizure medication portfolio (brivaracetam, fenfluramine, lacosamide, and midazolam nasal spray) will be presented at the 76th American Epilepsy Society (AES) Annual Meeting (Nashville, Tennessee), December 2-6.

Protagonist Therapeutics, Inc. (Nasdaq: PTGX) (“Protagonist” or “the Company”) today announced that Dinesh V. Patel , Ph.D., President and Chief Executive Officer, will participate in a fireside chat presentation and host one-on-one meetings with investors at the JMP Securities Hematology and Oncology Summit, a virtual investor event taking place December 6-7, 2022.

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) today announced that Steve Hoerter, President and Chief Executive Officer, will participate in a virtual fireside chat at the JMP Securities Hematology and Oncology Summit on Tuesday, December 6, 2022 at 10:40 AM ET.

Emergent Health Corp. announces its future products will be based upon Naturally inspired Regenerative Health Products, products that support human and pet cells, tissues, or organs to promote or establish normal function.